首页> 外文期刊>BMC Cancer >p300 promotes proliferation, migration, and invasion via inducing epithelial-mesenchymal transition in non-small cell lung cancer cells
【24h】

p300 promotes proliferation, migration, and invasion via inducing epithelial-mesenchymal transition in non-small cell lung cancer cells

机译:p300通过诱导非小细胞肺癌细胞的上皮-间质转化来促进增殖,迁移和侵袭

获取原文
           

摘要

Histone acetyltransferase p300 is a crucial transcriptional coactivator and has been implicated as a poor prognostic factor in human cancers. However, little is known about the substantial functions and mechanisms of p300 in NSCLC proliferation and distant metastasis. We constructed p300 down-regulated and up-regulated cell lines through RNAi and recombinant plasmid transfection. Cell Counting Kit-8 assays were used to test the cell proliferation and confirmed by colony formation assays. Wound healing assays and transwell chamber assays were used to test the migration and invasion ability. Based upon these results, we measured the epithelial markers and mesenchymal markers after regulating p300 expression to explore epithelial-mesenchymal transition as a potential mechanism of p300 promoting NSCLC metastasis. In NSCLC cells NCI-H1975 and NCI-H1993, down-regulation of p300 leads to inhibition of cell proliferation and colony formation. Cells with reduced p300 expression also demonstrate inhibited migration and invasion ability. Contrarily, up-regulation of p300 significantly enhanced the proliferation, colony formation, migration and invasion ability of NCI-H460. Importantly, further investigation shows that decreased p300 expression is associated with reduced expression of mesenchymal markers and increased expression of epithelial markers, while up-regulated p300 expression correlated with decreased expression of epithelial markers and increased expression of mesenchymal markers. As a crucial tumor promoter, p300 promotes cell proliferation, migration, and invasion in NSCLC cells. Epithelial-mesenchymal transition is a potential mechanism of p300 promoting NSCLC metastasis.
机译:组蛋白乙酰转移酶p300是关键的转录共激活因子,已被认为是人类癌症的不良预后因素。然而,关于p300在NSCLC增殖和远处转移中的实质功能和机制的了解甚少。我们通过RNAi和重组质粒转染构建了p300下调和上调的细胞系。细胞计数试剂盒8检测用于测试细胞增殖,并通过集落形成检测进行确认。伤口愈合测定法和transwell室测定法用于测试迁移和侵袭能力。基于这些结果,我们在调节p300表达后测量了上皮标志物和间充质标志物,以探讨上皮-间质转化是p300促进NSCLC转移的潜在机制。在NSCLC细胞NCI-H1975和NCI-H1993中,p300的下调导致细胞增殖和集落形成的抑制。 p300表达降低的细胞也显示出抑制的迁移和侵袭能力。相反,p300的上调显着增强了NCI-H460的增殖,集落形成,迁移和侵袭能力。重要的是,进一步的研究表明,p300表达的降低与间充质标记物的表达降低和上皮标记物的表达增加有关,而p300表达上调与上皮标记物的表达减少和间质标记物的表达增加相关。作为重要的肿瘤启动子,p300促进NSCLC细胞中的细胞增殖,迁移和侵袭。上皮-间质转化是p300促进NSCLC转移的潜在机制。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号